Herantis' phase I/II study of CDNF for Parkinson's meets primary endpoint of safety and tolerability Sep. 2, 2020
Prevail opens phase I/II study of PR-006 in frontotemporal dementia with progranulin mutations Sep. 1, 2020
FDA approves Xaracoll for acute postsurgical pain relief following open inguinal hernia repair Sep. 1, 2020
GNE-565: a Nav1.7 inhibitor with oral activity in a mouse model of Nav.17-associated pain Aug. 28, 2020
New neurotensin receptor type 2 agonists patented by Socpra Sciences Sante et Humaines SEC Aug. 28, 2020
RSS